ABS ePoster Library

Identification of DAP3 and HSP90 interaction and potential clinical implications in Breast cancer
Association of Breast Surgery ePoster Library. Uhercik M. 05/15/17; 166295; P011
Michal Uhercik
Michal Uhercik
Login now to access Regular content available to all registered users.
Abstract
Rate & Comment (0)
Introduction: Death associated protein 3 (DAP3) is a relatively novel proapoptotic and antioncogenic protein. HSP90 is a heat shock protein identified as a chaperone protein. We investigated the interaction between HSP90 and DAP3 in breast cancer cell lines and the clinical significance of HSP90.
Methods: Conventional PCR was used to screen DAP3 and HSP90 expression in 8 breast cancer cell lines. To explore potential DAP3 interacting partners, paired normal and cancerous breast tissues were immunoprecipitated with a DAP3 antibody before being probed on a protein microarray and further confirmed using Western Blot co-immunoprecipitation in MCF7 cells. Expression of HSP90a and HSP90b in a breast cancer cohort (n=143) was explored with regards to incidence of local recurrence and metastasis.
Results: Conventional PCR demonstrated a similar expression pattern of DAP3 and HSP90 in breast cancer cell lines (n=8). Protein microarray (Kinexus) analysis, following DAP3 immunoprecipitation highlighted an interaction between DAP3 and HSP90. Western Blot co-immunoprecipitation in MCF7 cells similarly highlighted this interaction. Low expression of HSP90 in breast cancer tissue was linked to local recurrence and metastasis.
Conclusions: HSP90 and DAP3 seem to have similar expression patterns across a range of breast cancer cell lines and in our clinical cohort lower expression levels suggest an association with metastasis and local recurrence. Current data implies that there may be a link between HSP90 and DAP3 and this may have functional significance in breast cancer progression.
Introduction: Death associated protein 3 (DAP3) is a relatively novel proapoptotic and antioncogenic protein. HSP90 is a heat shock protein identified as a chaperone protein. We investigated the interaction between HSP90 and DAP3 in breast cancer cell lines and the clinical significance of HSP90.
Methods: Conventional PCR was used to screen DAP3 and HSP90 expression in 8 breast cancer cell lines. To explore potential DAP3 interacting partners, paired normal and cancerous breast tissues were immunoprecipitated with a DAP3 antibody before being probed on a protein microarray and further confirmed using Western Blot co-immunoprecipitation in MCF7 cells. Expression of HSP90a and HSP90b in a breast cancer cohort (n=143) was explored with regards to incidence of local recurrence and metastasis.
Results: Conventional PCR demonstrated a similar expression pattern of DAP3 and HSP90 in breast cancer cell lines (n=8). Protein microarray (Kinexus) analysis, following DAP3 immunoprecipitation highlighted an interaction between DAP3 and HSP90. Western Blot co-immunoprecipitation in MCF7 cells similarly highlighted this interaction. Low expression of HSP90 in breast cancer tissue was linked to local recurrence and metastasis.
Conclusions: HSP90 and DAP3 seem to have similar expression patterns across a range of breast cancer cell lines and in our clinical cohort lower expression levels suggest an association with metastasis and local recurrence. Current data implies that there may be a link between HSP90 and DAP3 and this may have functional significance in breast cancer progression.
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies